* WHO added 20 adult and 15 child medicines to its essential list * Cancer immunotherapies and GLP-1 diabetes drugs now included * Experts warn affordability and fair access //remain major barriers ...
Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter ...
The World Health Organization (WHO) has officially included GLP-1 receptor agonists, such as Novo Nordisk’s Ozempic and Eli Lilly’s Mounjaro, in its Model List of Essential Medicines (EML). This ...
Fifteen prescription medications, including Botox and the diabetes drug Trulicity, will be the focus of federal price negotiations that could lower prices for Medicare patients. An outgrowth of the ...